GlycoLeap, developed by Holmusk, combines expert human coaching with mobile technology to empower people with Type 2 Diabetes to live a healthier life.
Holmusk, a digital health and data analytics company, has just launched its flagship product, a smart coach for type 2 diabetes. Called GlycoLeap, it delivers human coaching via a mobile app and integrates connected health tracking tools. The app is available for iOS and Android.
“GlycoLeap is transformative for people with diabetes, especially in the way it brings diabetes care out of the clinics and hospitals and into people’s every day lives”, said Nawal Roy, CEO and Founder of Holmusk. “We want to contribute towards revolutionising the healthcare experience for people living with chronic disease.”
Diabetes affects more than 415 million people worldwide; a number that continues to rise each year. A 2015 study by the International Diabetes Federation (IDF) found that Singapore has the second-highest proportion of people with diabetes among all developed nations – more than 10 percent of people aged 20 to 79. Three out of every 10 patients with diabetes develop the condition before age 40.
GlycoLeap uses concepts from behavioural science to drive positive health outcomes for people with diabetes. Through small and sustainable lifestyle changes, users can achieve moderate weight loss and improve glucose control (as measured by HbA1c) within 6-months of the GlycoLeap program.
As part of the program, users take photographs of their meals with Glyco app. A coaching team of qualified dietitians rate the meals and provide daily feedback and support. Users are also provided smart devices, including a wireless scale, glucometer and fitness band to track weight, blood glucose and physical activity. This gives the coaching team a 360-degree view of each user’s behaviour, allowing them to provide the right feedback and support at the right time.
“After using GlycoLeap for 6 months, my HbA1c was reduced from 8.7 to 6.2 percent,” said Singapore user Wen Shi. “The feedback provided by the dietitians on food rating has helped me realise what types of food are good at controlling my glucose.”
Healthcare costs associated with diabetes continue to be a major concern world wide. Diabetes-related complications are a major cause of hospitalisation. According to a 2016 article in the BMC Public Health journal, Singapore’s healthcare spending for diabetes rose above $1 billion in 2010, and is expected to soar beyond $2.5 billion by 2050.
The high costs of diabetes – both for the individual and the healthcare system – and the personal nature of diabetes management, presents an opportunity for technologies that can provide scalable and engaging solutions for better diabetes management. GlycoLeap has the potential to fill this need.
Plans are currently in the works to develop tailored programs for people with prediabetes – as well as other chronic diseases, such as high blood pressure and high cholesterol – in the next 6 months.
GlycoLeap is currently available in Singapore, and expected to become available in the United States, Malaysia and Hong Kong by early 2017.
Please visit https://glycoleap.com/ and register today – it’s free to try. Available for iPhone and Android.
GlycoLeap is a smart coach for type 2 diabetes that you can access anytime, anywhere. It provides you with the support you need to reach your health goals in less time, such as better glucose control, a healthier weight, and keeping up with exercise and diet changes. We combine human expert coaching with smart technology – all from your smartphone. We believe that everyone has the power to transform their life in a sustainable way, if given the right support. Diabetes does not have to be complicated or difficult. And we’ve done this with GlycoLeap – beautifully designed, simple to use and convenient.
Holmusk is a global digital health and data analytics company, focused on solving complex problems in healthcare for chronic diseases. We build innovative, scalable and cost-effective digital behaviour change programs that combine cutting-edge clinical research, technology and design to nudge people towards sustainable changes for better health. We develop powerful predictive algorithms that offer actionable insights for personalised care and population health management. We are based in Singapore and USA.
For Media Enquires, please contact:
+65 6250 4233